Weekly Rundown: Small-Cap Stocks with Key Catalysts (June 30–July 3)

Note: Markets close early at 1 PM on July 3 and are closed on July 4.

Stay ahead with our latest insights on small-cap movers. We're spotlighting recent filings, breaking news, and key investor updates from small-cap companies. This weekly summary is built to keep you informed and in the loop. Here are the top developments we're tracking for the week of June 30–July 3.

--

Companies with Key Catalysts This Week:

ACRS > Will provide a corporate presentation during the H.C. Wainwright Inflammation & Immunology Virtual Conference. The presentation will take place on Monday, June 30, 2025.

OXBR > Through its subsidiary SurancePlus, announced its participation in the upcoming Ethereum Community Conference (EthCC) taking place in Cannes, France, from June 30 to July 3, 2025.

TIVC > The Company will hold its Virtual Annual General Meeting of Shareholders on Monday, June 30, 2025, at 1:00 PM Pacific Time (4:00 PM Eastern Time). The meeting will be conducted entirely online to ensure accessibility for all shareholders, regardless of location. While there will be no live Q&A session, shareholders may submit questions for management either before or during the meeting via the virtual meeting platform.

ZSPC > Participation in the ISTE Live 25 Conference, taking place June 30–July 2 at the Henry B. González Convention Center in San Antonio, Texas.

PHIO > CEO Robert Bitterman will present an update on the company’s INTASYL siRNA technology and lead compound PH-762 for skin cancer treatment during the Virtual Non-Deal Roadshow hosted by Renmark Financial on Monday, June 30, 2025, at 10:00 AM EST, following recent positive interim results from the ongoing Phase 1b trial.

AVTX > HCW Annual Inflammation & Immunology Virtual Conference Fireside Chat on June 30, 2025, at 11:00 am ET.

NLSP > In January 2025, following board approval from both NLS and Kadimastem, Kadimastem’s shareholders overwhelmingly approved the merger, marking a key milestone in uniting the complementary strengths of the two companies. Amendments to the Form F-4 Registration Statements were filed to support the final NLS shareholder vote. The merger process is currently progressing, with completion targeted for early Q3 2025, pending fulfillment of all regulatory requirements.

MGLD > The company has entered into a stock purchase agreement to sell its wholly owned Canadian subsidiary, Brigadier Security Systems Ltd. ("Brigadier"), to SKCAL LLC, an Arizona LLC solely owned by a TMC director and 11% shareholder. The transaction, expected to close on or about July 1, 2025, aligns with the company’s strategy to focus resources on growth in the financial services sector, with total consideration estimated at approximately US $2.2 million.

GPUS > On or about July 1, 2025, we will also accept $PEPE, marking three meme coins as an accepted payment method on Bitnile.com, with more expected to come this year.

XHLD > The Company announced the launch of its Early Adopter Program for Ten Events Pro (“Ten Pro”), its new SaaS product, beginning July 1, 2025. This initiative offers selected companies exclusive early access to the beta version of Ten Pro, enabling them to provide feedback and help shape the platform ahead of its public release, while positioning the Company for scalable, higher-margin growth.

CVAC > Core mRNA patents upheld as European Patent Office confirmed validity of two key patents in amended form; infringement hearing against BioNTech/Pfizer before the Regional Court Düsseldorf set for July 1, 2025.

AXL > AAM's outlook assumes the sale of AAM's commercial vehicle axle business in India is completed by July 1, 2025.

LSTA > Promising positive preliminary Cohort B data from the ASCEND Phase 2b trial (NCT05042128) in metastatic pancreatic cancer, with AGITG sponsoring the study and Lisata providing funding. Dr. Andrew Dean, Study Chair, is scheduled to present these findings at the European Society for Medical Oncology ("ESMO") Gastrointestinal Cancers Congress in Barcelona, Spain, on 2 July, 2025.

IMDX > Extended data from the study will be presented in a poster abstract at the upcoming European Society of Organ Transplantation (ESOT) Congress, being held in London from June 29th through July 2nd.

IMAB > Positive initial data from the Phase 1b dose escalation study of givastomig in gastric cancers at ESMO GI 2025 on July 2nd.

MYND > Expansion of its award-winning ActivPanel display portfolio. Alongside ActivPanel 10 and ActivPanel 10 Premium, Promethean is globally launching two additional displays with phased availability. The company will showcase its full fleet of ActivPanel displays at ISTELive 2025 in San Antonio, TX, June 29-July 2.

BW > The company announced on June 5, 2025, that it reached an agreement to sell its Diamond Power International business ("Diamond Power") to Austria-based ANDRITZ for $177 million, subject to customary fees and adjustments. The sale is expected to close within approximately 30 days—by around July 5, 2025—and will include the transfer of approximately 400 employees to ANDRITZ.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.